FDA updates labeling for RIFATER
Labeling changes approved for SANOFI AVENTIS US. Active ingredient: ISONIAZID; PYRAZINAMIDE; RIFAMPIN. Decision date: 12/05/2025
Labeling changes approved for SANOFI AVENTIS US. Active ingredient: ISONIAZID; PYRAZINAMIDE; RIFAMPIN. Decision date: 12/05/2025
There are no comments here yet...